1. Introduction

molecules

Molecules

1420-3049

MDPI

10.3390/molecules17044498

molecules-17-04498

Article

Regioselectivity in the Ring Opening of Epoxides for the Synthesis of Aminocyclitols from D-(−)-Quinic Acid

Shih

Tzenge-Lien

* Yang

Shu-Yu

Department of Chemistry, Tamkang University, No151 Yingzhuan Rd, 25137 Tamsui Dist., New Taipei City, Taiwan; Email: 699180088@s99.tku.edu.tw

* Author to whom correspondence should be addressed; Email: tlshih@mail.tku.edu.tw; Tel./Fax: +886-2-8631-5024.

16 04 2012

04 2012

17 4 4498 4507 26 03 2012 09 04 2012 10 04 2012

2012

This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).

Efficient syntheses of four aminocyclitols are reported. Each synthesis is accomplished in eight steps starting from D-(−)-quinic acid. The key step involves a highly regioselective ring opening of epoxides by sodium azide.

aminocyclitols epoxides glycosidase inhibitors D-(−)-quinic acid regioselective ring opening

1. Introduction

Aminocyclitols, also known as aminocarbasugars [1], contain at least one amino or substituted amino moiety in the cyclitols (polyhydroxylated cycloalkanes) [2]. Many natural and synthetic products containing aminocyclitol scaffolds have shown a variety of biological activities [3,4], such as, valienamine [5], pancratistatin [6], oseltamivir [7], and voglibose [4] (Figure 1). The synthesis of biological active aminocyclitols and assessment of their structure and activity relationship have generated considerable interest in recent years [4,8,9,10,11,12,13,14,15,16,17].

Previously, we have synthesized three aminocyclitols from D-(−)-quinic acid in nine to ten steps via stereoselective dihydroxylation as a key step [18] (Figure 2). These quercitol-like structures of aminocyclitols are also called as deoxyinosamines [4]. We described herein an alternative synthesis of two known aminocyclitols 5 and 6 along with two new aminocyclitols 10 and 11. The synthesis was accomplished in eight steps via a regioselective ring opening reaction of epoxides.

Figure 1

Representative natural or synthetic products containing aminocyclitol moiety.

Figure 2

The previously synthesized aminocyclitols.

2. Results and Discussion

Unlike the strategy we previously used in the synthesis of aminocyclitols (Figure 2), we started from the epoxides 1, 2 and 7, which were prepared from D-(−)-quinic acid in six steps, respectively [19]. When compounds 1 and 2 were treated with sodium azide in DMF under reflux conditions, they underwent a highly regioselective opening at the C4 position to afford 3 and 4, respectively (Scheme 1).

molecules-17-04498-f003_Scheme 1

Scheme 1

Synthesis of aminocyclitols 5, 6, 10 and 11.

The yields were mediocre but no other regioisomers were detected by TLC or isolated from column purification [20]. Interestingly, the TMB-protected compound 7 was treated with NaN₃ to afford 8 in 71% yield and its epimer 9 in 14% yield. The azide directly attacked the least hindered side of 7 at the C4 position to give 8. However, a plausible mechanism for the formation of the minor component 9 results from the C5 hydroxide group of 7 being attacked at the C4 position to give intermediate 12a (Figure 3).

Figure 3

Plausible mechanism for the formation of 9.

Instead of attack at the least hindered side at the C5 position of 12a by azide, known as the Payne rearrangement [21], the hydroxide group at C3 of 12a internally removed the proton of HN₃ (intermediate 12b). That allowed the resulting azide to attack the vicinal C4 position of 12b to give 9. This resulted in the retention of configuration of epoxide 7. This observation was very unusual and in contrast to the results that occurred in the 2,3-epoxy rearrangement [22]. Based on the Chem3D simulation, the cyclohexane core of 7 was in a boat-like conformation (Figure 4). The trans-diaxial attack at C4 in 7 by azide leading to 8 as the major compound was energetically favorable. However, we could not rule out the possibility in formation of 12a which was derived from the trans-axial attack of the epoxide by C5-OH in 7. The lower yield of 9 was probably due to the half-chair like structure 12a that was less favorable than 7 for allowing by azide attack (Figure 4).

Figure 4

Three-dimensional representations of structures 7 and 12a.

The Payne rearrangement of epoxide 7 intrigued us as an interesting issue when no rearrangement product 13 was found when compound 1 was treated with NaN₃ (Figure 5). According to the Chem3D simulation, the conformation of cyclohexane core of 1 is a slightly twisted boat form. However, compound 13 was in a boat conformation if the Payne rearrangement occurred. The reason was probably due to the steric congestion in the formation of 13 because the distance between epoxide and the C2 acetal oxygen atom of 13 is around 3.054 Å. On the contrary, the distance between the C5-OH and C2 oxygen atom of 1 is about 3.328 Å. Therefore, the trans-diaxial attack at C4 of 1 by azide might be kinetically or sterically controlled to lead to the major component 3.

Figure 5

Three-dimensional representations of structures 1 and 13.

In order to obtain better yields of final products 5, 6, 10, and 11, we determined that azido compounds 3, 4, 8, and 9 should be hydrogenated first over Pd/C, followed by deprotection under acidic conditions. The one pot reaction conditions (H₂/Pd/C/HCl) afforded low yields of target compounds accompanied by a more complicated mixture. It is worth noting that our strategy was much shorter than the reported method in the syntheses of molecules 5 and 6 which involved sixteen steps starting from D-mannitol [23]. The structure determinations were based on a series of NMR experiments (COSY, 2D-NOESY, HMBC, HMQC, and HRMS) and the selected NMR data were listed on Table 1 and Table 2.

molecules-17-04498-t001_Table 1

Table 1

Selected ¹H (600 MHz) and ¹³C (150 MHz) NMR data for 3, 4, 8, and 9 in CD₃OD.

Compound	H₁ ( J)/C₁	H₂ ( J)/C₂	H₃ ( J)/C₃	H₄ ( J)/C₄	H₅ ( J)/C₅	H₆ ( J)/C₆
3	4.33–4.30 (m) 74.7	3.92 (dd, 7.0, 5.3) 81.4	4.04–4.01 (m) 69.3	3.21 (dd, 10.0, 2.7) 86.8	4.07–4.04 (m) 71.9	2.25 (dt, 15.7, 3.6) 1.93 (ddd, 15.7, 7.1, 3.7) 32.1
4	4.30 (dt, 6.5, 2.3) 74.1	3.89 (dd, 7.6, 5.2) 81.0	3.38 (dd, 10.4, 7.6) 76.1	3.04 (t, 10.2) 71.5	3.62 (td, 11.2, 4.9) 68.6	2.34 (ddd, 14.9, 4.9, 2.2) 1.75 (ddd, 14.9, 11.5, 4.1) 34.1
8	3.88 (ddd, 11.6, 10.1, 4.7) 65.3	3.95 (dd, 10.0, 3.4) 71.1	3.85 (t, 3.5) 64.5	3.79 (t, 3.0) 72.5	3.74 (ddd, 11.6, 5.2, 3.0) 67.6	1.79–1.74 (m) 1.71 (t, 11.6) 32.8
9	3.51–3.40 (m) 66.1	3.78 (tm, 9.5, 0.8) 75.0	3.32 (td, 9.4, 0.8) 72.3	3.13 (td, 9.5, 1.7) 73.0	3.45–3.42 (m) 69.7	2.01 (dt, 12.1, 4.6) 1.51 (ddd, 13.3, 12.3, 1.4) 36.3

molecules-17-04498-t002_Table 2

Table 2

Selected ¹H (600 MHz) and ¹³C (150 MHz) NMR data for 5, 6, 10, and 11 in D₂O.

Compound	H₁ ( J)/C₁	H₂ ( J)/C₂	H₃ ( J)/C₃	H₄ ( J)/C₄	H₅ ( J)/C₅	H₆ ( J)/C₆
5	4.03 (dd, 6.3, 3.1) 70.0	3.45 (dd, 9.4, 2.8) 73.8	3.90 (t, 9.8) 67.2	3.12 (d, 10.3, 3.2) 56.7	4.09 (dd, 6.5, 3.2) 66.9	2.08 (dt, 15.6, 3.5) 1.70 (dt, 15.6, 2.9) 32.6
6	3.96–3.94 (m) 68.3	3.41–3.34 (m)^a 73.9	3.41–3.34 (m)^a 71.7	2.53 (t, 9.8) 59.4	3.59 (ddd, 14.5, 10.0, 4.6) 67.6	1.98 (dt, 14.0, 4.2) 1.47 (td, 14.0, 2.5) 36.3
10	3.91 (dt, 9.1, 3.5) 67.0	3.75–3.65 (m)^a 68.3	3.75–3.65 (m)^a 67.2	3.12 (t, 4.0) 52.6	3.75–3.65 (m)^a 72.1	1.85 (td, 13.1, 4.1) 1.75–1.62 (m) 32.9
11	3.39 (ddd, 11.9, 9.4, 4.6) 68.6	3.15 (t, 9.3) 77.0	2.99 (t, 9.6) 74.0	2.49 (d, 9.8) 58.8	3.30 (td, 11.4, 4.4) 68.7	2.06 (dt, 12.2, 4.5) 1.35 (dd, 11.9, 11.9) 68.6

^a Assignments were not well resolved due to signal overlaps.

3. Experimental 3.1. General Methods

¹H (600 MHz) and ¹³C-NMR (150 MHz) spectra were recorded on a Bruker 600 MHz instrument. The chemical shifts were reported in ppm and relative to the residual of d-solvents: CD₃OD (¹H, 4.78 ppm; ¹³C, 49.0 ppm); D₂O (4.69 ppm). Optical rotations were measured with a HORIBA SEPA-300 instrument. HRMS were measured by a Finnigan MAT 95S spectrometer.

3.2. General Procedure of Ring Opening

Compound 1 (0.838 g, 4.0 mmol), for example, was dissolved in DMF (30 mL). To this mixture was added NaN₃ (2.3 g, 36.0 mmol) and a catalytic amount of 15-crown-5 and heated under reflux for 5−6 h. At the end of the reaction time, the mixture was diluted with H₂O (100 mL) and extracted with Et₂O (2x100 mL). The organic layer was dried (MgSO₄) and purified by column chromatography.

3.3. General Procedures of Hydrogenation and Deprotection

Compound 3 (0.079 g, 0.29 mmol) for example, was dissolved in MeOH (2 mL). To this mixture was added 10% Pd/C (10 mol%) and it was hydrogenated under one atmosphere at ambient temperature for 2 h. The resulting mixture was filtrated through a pad of Celite and washed with MeOH. The organic layer was concentrated and 80% TFA was added (2 mL), then stirred for 1−1.5 h, at the end of which time, the solvent was evaporated and the residue purified by column chromatography.

3.4. Synthesis of the Key Intermediates and the Target Molecules 3.4.1. (1R,2R,3R,4S,5S)-4-Azido-1,2-O-cyclohexylidene-cyclohexane-1,2,3,5-tetraol (<bold>3</bold>)

Purification by flash column chromatography (230–400 mesh SiO₂, EtOAc/hex = 1/8−1/2) afforded a white solid. Yield = 67%. MP = 122−128 °C. [α]_D²⁵ +36.2 (c 0.31, MeOH). ¹H-NMR (CD₃OD)δ 4.56 (s, 2H, -OH), 4.33−4.30 (m, 1H), 4.07−4.04 (m, 1H), 4.04−4.01 (m, 1H), 3.92 (dd, J = 7.0, 5.3 Hz, 1H), 3.21 (dd, J = 10.0, 2.7 Hz, 1H), 2.25 (dt, J = 15.7, 3.6 Hz, 1H), 1.93 (ddd, J = 15.7, 7.1, 3.7 Hz, 1H), 1.72−1.54 (m, 8H), 1.48−1.42 (m, 2H). ¹³C-NMR (CDCl₃) δ 110.7, 81.4, 74.7, 71.9, 69.3, 66.8, 39.4, 36.2, 32.1, 26.2, 25.1, 24.8. HRMS (ESI) calcd for C₁₂H₁₉N₃O₄ (M⁺) 269.1376. Found: 269.1371.

3.4.2. (1R,2R,3R,4S,5R)-4-Azido-1,2-O-cyclohexylidene-cyclohexane-1,2,3,5-tetraol (<bold>4</bold>)

Purification by flash column chromatography (230−400 mesh SiO₂, EtOAc/hex = 1/8−1/2) afforded a white solid. Yield = 69%. Mp = 125−130 °C. [α]_D²⁵−146.6 (c 0.45, MeOH). ¹H-NMR (CD₃OD) δ 4.57 (s, 2H, -OH), 4.30 (dt, J = 6.5, 2.3 Hz,1H), 3.89 (dd, J = 7.6, 5.2 Hz, 1H), 3.62 (td, J = 11.2, 4.9 Hz, 1H), 3.38 (dd, J = 10.4, 7.6 Hz, 1H), 3.04 (t, J = 10.2 Hz, 1H), 2.34 (ddd, J = 14.9, 4.9, 2.2 Hz, 1H), 1.75 (ddd, J = 14.9, 11.5, 4.1 Hz, 1H), 1.70−1.52 (m, 8H), 1.44−1.40 (m, 1H), 1.39−1.30 (m, 1H).¹³C-NMR (CD₃OD) δ 110.8, 81.0, 76.1, 74.1, 71.5, 68.6, 39.3, 36.2, 34.1, 26.1, 25.0, 24.8. HRMS (ESI) calcd for C₁₂H₁₉N₃O₄ (M⁺) 269.1376. Found: 269.1377.

3.4.3. (1R,2S,3R,4S,5S)-4-Azido-1,2-[(2S,3S)-2,3-dimethoxybutan-2,3-dioxy]-cyclohexane-1,2,3,5-tetraol (<bold>8</bold>)

Purification by flash column chromatography (230–400 mesh SiO₂, EtOAc/hex = 1/15−1/2) afforded a white solid. Yield = 71%. MP = 178−182 °C. [α]_D²⁵ +157.4 (c 0.19, MeOH). ¹H-NMR (CD₃OD) δ 3.95 (dd, J = 10.0, 3.4 Hz, 1H), 3.88 (ddd, J = 11.6, 10.1, 4.7 Hz, 1H), 3.85 (t, J = 3.5 Hz, 1H), 3.79 (t, J = 3.0 Hz, 1H), 3.74 (ddd, J = 11.6, 5.2, 3.0 Hz, 1H), 3.24 (s, 6H), 1.79−1.74 (m, 1H), 1.71 (t, J = 11.6 Hz, 1H), 1.28 (s, 3H), 1.24 (s, 3H). ¹³C-NMR (CD₃OD) δ 101.4, 100.6, 72.5, 71.1, 67.6, 65.3, 64.5, 48.2, 48.1, 32.8, 18.0, 17.9. HRMS (ESI) calcd for C₁₂H₂₁N₃NaO₆ [M+Na]⁺ 326.1328. Found: 326.1308.

3.4.4. (1R,2S,3R,4R,5S)-4-Azido-1,2-[(2S,3S)-2,3-dimethoxybutan-2,3-dioxy]-cyclohexane-1,2,3,5-tetraol (<bold>9</bold>)

Purification by flash column chromatography (230–400 mesh SiO₂, EtOAc/hex = 1/15−1/2) afforded a white solid. Mp = 179−185 °C. Yield = 14%. [α]_D²⁵ +164.3 (c 0.28, MeOH). ¹H-NMR (CD₃OD) δ 3.78 (td, J = 9.5, 0.8 Hz, 1H), 3.51−3.40 (m, 2H), 3.32 (td, J = 9.4, 0.8 Hz, 1H), 3.27 (s, 3H), 3.21 (s, 3H), 3.13 (td, J = 9.5, 1.7 Hz, 1H), 2.01 (dt, J = 12.1, 4.6 Hz, 1H), 1.51 (ddd, J = 13.3, 12.3, 1.4 Hz, 1H), 1.27 (s, 3H), 1.24 (s, 3H). ¹³C-NMR (CD₃OD) δ 100.7 (×2), 75.0, 73.2, 72.3, 69.7, 66.1, 48.3, 48.2, 36.3, 17.9 (x2). HRMS (ESI) calcd for C₁₂H₂₁N₃NaO₆ [M+Na]⁺ 326.1328. Found: 326.1328.

3.4.5. (1R,2R,3R,4S,5S)-4-Aminocyclohexane-1,2,3,5-tetraol (<bold>5</bold>)

Purification by flash column chromatography (230–400 mesh SiO₂, MeOH/CH₂Cl₂/5%NH₄OH = 1/10−1/1) afforded a pale yellow syrup. Yield = 70%. [α]_D²⁵−76.7 (c 0.21, H₂O). ¹H-NMR (D₂O) δ 4.09 (dd, J = 6.5, 3.2 Hz, 1H), 4.03 (dd, J = 6.3, 3.1 Hz, 1H), 3.90 (t, J = 9.8 Hz, 1H), 3.45 (dd, J = 9.4, 2.8 Hz, 1H), 3.12 (dd, J = 10.3, 3.2 Hz, 1H), 2.08 (dt, J = 15.6, 3.5 Hz, 1H), 1.70 (dt, J = 15.6, 2.9 Hz, 1H). ¹³C-NMR (D₂O) δ 73.8, 70.0, 67.2, 66.9, 56.7, 32.6. HRMS (ESI) calcd for C₆H₁₄NO₄ [M+H]⁺ 164.0923. Found: 164.0919.

3.4.6. (1R,2R,3R,4S,5R)-4-Aminocyclohexane-1,2,3,5-tetraol (<bold>6</bold>)

Purification by flash column chromatography (230–400 mesh SiO₂, MeOH/CH₂Cl₂/5%NH₄OH = 1/10−1/1) afforded a pale yellow syrup. Yield = 71%. [α]_D²⁵−19.4 (c 0.33, H₂O). ¹H-NMR (D₂O) δ 3.96−3.94 (m, 1H), 3.59 (ddd, J = 14.5, 10.0, 4.6 Hz, 1H), 3.41−3.34 (m, 2H), 2.53 (t, J = 9.8 Hz, 1H), 1.98 (dt, J = 14.0, 4.2 Hz, 1H), 1.47 (td, J = 14.0, 2.5 Hz, 1H). ¹³C-NMR (D₂O) δ 73.9, 71.7, 68.3, 67.6, 59.4, 36.3. HRMS (ESI) calcd for C₆H₁₃NO₄ (M⁺) 163.0845. Found: 163.0835.

3.4.7. (1R,2S,3R,4S,5S)-4-Aminocyclohexane-1,2,3,5-tetraol (<bold>10</bold>)

Purification by flash column chromatography (230–400 mesh SiO₂, MeOH/CH₂Cl₂/5%NH₄OH = 1/10−1/1) afforded a pale yellow syrup. Yield = 73%. [α]_D²⁵−48.2 (c 0.19, H₂O). ¹H-NMR (D₂O) δ 3.91 (dt, J = 9.1, 3.5 Hz, 1H), 3.75−3.65 (m, 3H), 3.12 (t, J = 4.0 Hz, 1H), 1.85 (dt, J = 13.1, 4.1 Hz, 1H), 1.75−1.62 (m, 1H). ¹³C-NMR (D₂O) δ 72.1, 68.3, 67.2, 67.0, 52.6, 32.9. HRMS (ESI) calcd for C₆H₁₄NO₄ [M+H]⁺ 164.0923. Found: 164.0920.

3.4.8. (1R,2S,3R,4R,5S)-4-Aminocyclohexane-1,2,3,5-tetraol (<bold>11</bold>)

Purification by flash column chromatography (230–400 mesh SiO₂, MeOH/CH₂Cl₂/5%NH₄OH = 1/10−1/1) afforded a pale yellow syrup. Yield = 68%. [α]_D²⁵−69.4 (c 0.18, H₂O). ¹H-NMR (D₂O) δ 3.39 (ddd, J = 11.9, 9.4, 4.6 Hz, 1H), 3.30 (td, J = 11.4, 4.4 Hz, 1H), 3.15 (t, J = 9.3 Hz, 1H), 2.99 (t, J = 9.6 Hz, 1H), 2.49 (t, J = 9.8 Hz, 1H), 2.06 (dt, J = 12.2, 4.5 Hz, 1H), 1.35 (dd, J = 11.9, 11.9 Hz, 1H). ¹³C-NMR (D₂O) δ 77.3, 74.0, 68.7, 68.6, 58.8, 38.0. HRMS (ESI) calcd for C₆H₁₄NO₄ [M+H]⁺ 164.0923. Found: 164.0918.

4. Conclusions

In conclusion, aminocyclitols are a very important class of aminocarbasugars. We have synthesized two known and two new aminocyclitols in an efficient manner from D-(−)-quinic acid. Especially, our method provided a short alternative in syntheses of 5 and 6 than the literature. The ring opening of epoxide in 1, 2 and 7 by sodium azide to provide moderate to good yields of 3, 4, and 8, respectively, was highly regioselective owing to the steric effect. The studies of the biological activities of these compounds are currently ongoing and will be reported in due course.

Acknowledgments

The National Science Council (NSC98-2119-M-032-004-MY3) and Tamkang University are gratefully acknowledged for the financial support of this research. Authors also thank the National Center for High-Performing Computing for assistance.

Conflicts of Interest

The authors declare no conflicts of interest.

References and Notes 1.

Arjona

Gomez

A.M.

Lopez

J.C.

Plumet

Synthesis and Conformational and Biological Aspects of Carbasugars

Chem. Rev. 2007 107 1919 2036

10.1021/cr0203701

17488060

2. IUPAC Commission on the Nomenclature of Organic Chemistry (CNOC) IUPAC-IUB Commission on Biochemical Nomenclature (CBN)

Nomenclature of Cyclitols

(accessed on 15 April 2012)

Available online:http://www.chem.qmul.ac.uk/iupac/cyclitol 3.

Duchek

Adams

D.R.

Hudlicky

Chemoenzymatic synthesis of inositol, conduritols, and cyclitol analogues

Chem. Rev. 2011 111 4223 4258

10.1021/cr1004138

Delgado

Recent advances in the chemistry of aminocyclitols

Eur. J. Org. Chem. 2008 2008 3893 3906 and references cited therein.

10.1002/ejoc.200800238

Mahmud

The C₇N aminocyclitol family of natural products

Nat. Prod. Rep. 2003 20 137 166

10.1039/b205561a

12636088

Dam

J.H.

Madsen

Convergent synthesis of pancratistatin from piperonal and xylose

Eur. J. Org. Chem. 2009 2009 4666 4673 references cited therein.

10.1002/ejoc.200900719

Sullivan

Carrera

Drouin

Hudlicky

Symmetry-based design for the chemoenzymatic synthesis of oseltamivir (Tamiflu) from ethyl benzoate

Angew.Chem. Int. Ed. 2009 48 4229 4231

10.1002/anie.200901345

Gupta

Pal

A.P.J.

Reddy

Y.S.

Vankar

Y.D.

Synthesis of aminocyclitols and trihydroxylated indolizidinone from a D-mannitol-derived common building block

Eur. J. Org. Chem. 2011 2011 1166 1175

10.1002/ejoc.201001171

Ahmad

Thomas

L.H.

Sutherland

Stereoselective synthesis of polyhydroxylated aminocyclohexanes

Org. Biomol. Chem. 2011 9 2801 2808

10.1039/c0ob00619j

21365097

10.

Harrak

Barra

C.M.

Delgado

Castaña

A.R.

Llebaria

Galacto-configured aminocyclitol phytoceramides are potent in vivo invariant natural killer T cell stimulators

J. Am. Chem. Soc. 2011 133 12079 12084

10.1021/ja202610x

21728320

11.

Díaz

Casas

Bujons

Llebaria

Delgado

New glucocerebrosidase inhibitors by exploration of chemical diversity of N-substituted aminocyclitols using click chemistry and in situ screening

J. Med. Chem. 2011 54 2069 2079

10.1021/jm101204u

21370884

12.

Díaz

Bujons

Casas

Llebaria

Delgado

Click chemistry approach to new N-substituted aminocyclitols as potential pharmacological chaperones for gaucher disease

J. Med. Chem. 2010 53 5248 5255

10.1021/jm100198t

20557054

13.

Kurbanoğlu

N.I.

Celik

Kilic

Alp

Sahin

Balci

Stereospecific synthesis of a DL-gala-aminoquercitol derivative

Tetrahedron 2010 66 3485 3489

10.1016/j.tet.2010.03.028

14.

Pandey

Tiwari

K.N.

Puranik

V.G.

Use of enantiomerically Pure 7-azabicyclo[2.2.1]heptan-2-ol as a chiral template for the synthesis of aminocyclitols

Org. Lett. 2008 10 3611 3614

10.1021/ol801381t

15.

Zhang

Y.-H.

Yao

Z.-J.

Parallel synthesis of individual shikimic acid-like molecules using a mixture-operation strategy and ring-closing enyne metathesis

Tetrahedron Lett. 2007 48 3511 3515

10.1016/j.tetlet.2007.03.118

16.

Alegret

Benet-Buchholz

Riera

Stereodivergent syntheses of conduramines and aminocyclitols

Org. Lett. 2006 8 3069 3072

10.1021/ol061022e

16805554

17.

Donohoe

Johnson

P.D.

Pye

R.J.

Keenan

Concise and enantioselective synthesis of the aminocyclitol core of hygromycin A

Org. Lett. 2005 7 1275 1277

10.1021/ol0473750

15787485

18.

Shih

T.-L.

H.-Y.

M.-S.

Kuo

W.-S.

Synthesis of a new family of aminocyclitols from D-(−)-quinic acid

Synth.Commun. 2008 38 4139 4149

10.1080/00397910802281429

19.

Shih

T.-L.

Lin

Y.-L.

Epoxidation of Protected (1,4,5)-cyclohex-2-ene-triols and their acid hydrolysis to synthesize quercitols from D-(−)-quinic acid

Synth.Commun. 2005 35 1809 1817

10.1081/SCC-200063960

20.

The crude mixture in reaction of molecule 1 by NaN₃ was measured by NMR spectra. An unidentified molecule with approximated 1.6% amount of 3 was detected. We suspected it was the other regioisomer but we failed to isolate it from column chromatography. On the other hand, we did not detect other isomers in reaction of molecule 2. The moderate yields obtained of 3 and 4 from 1 and 2, respectively, were due to their slight decomposition during reactions.

21.

Payne

G.B.

Epoxide migrations with a,β-epoxy alcohols

J. Org. Chem. 1962 27 3819 3822

10.1021/jo01058a015

22.

Behrens

C.H.

Sharpless

K.B.

New transformations of 2,3-epoxy alcohols and related derivatives Easy routes to homochiral substances

Aldrichim. Acta 1983 16 67 79 23.

The NMR data and optical rotation values of compounds 5 and 6 were reported to be dissolved in CDCl₃ and MeOH, respectively (see reference 8). But, in general, these compounds and other related analogues are more soluble in D₂O or CD₃OD than in CDCl₃. The NMR data and HRMS are satisfied for molecules 5 and 6.

Sample Availability: Samples of the compounds 1−11 are available from the authors.